methylphenobarbital Report issue

Small molecule Experimental
ChEMBL DrugBank Drug Central KEGG MeSH PubChem repoDB

Active Ingredient History

Mephobarbital us a barbiturate derivative used primary as an anticonvulsant, but also as a sedative and anxiolytic. Marketing of mephobarbital was discontinued in 2012.   NCATS

Chemistry

  • SMILES: CCC1(C(=O)NC(=O)N(C)C1=O)C2=CC=CC=C2
  • InChIKey: ALARQZQTBTVLJV-UHFFFAOYSA-N
  • Mol. Mass: 246.2619
  • ALogP: 1.04
  • ChEMBL Molecule:
    mephobarbital  
More Chemistry

Pharmacology

Alternative names

1-methylphenobarbital | 5-ethyl-1-methyl-5-phenyl-2,4,6(1h,3h,5h)-pyrimidinetrione | 5-ethyl-1-methyl-5-phenylbarbituric acid | 5-ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione | enphenemal | mebaral | menta-bal | mephobarbital | mephobarbitone | methylphenobarbital | méthylphénobarbital | methylphenobarbitalum | methylphenobarbitone | metilfenobarbital | metilfenobarbitale | metylfenemal | n-methylphenobarbital | prominal

Indications (2)

Approved Indications (2)


 

Anxiety

Epilepsy

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue